117 related articles for article (PubMed ID: 25422224)
1. New formulated "DOX-MTX-loaded nanoparticles" down- regulate HER2 gene expression and improve the clinical outcome in OSCCs model in rat: the effect of IV and oral modalities.
Abbasi MM; Monfaredan A; Hamishehkar H; Jahanban-Esfahlan R
Asian Pac J Cancer Prev; 2014; 15(21):9355-60. PubMed ID: 25422224
[TBL] [Abstract][Full Text] [Related]
2. Novel DOX-MTX nanoparticles improve oral SCC clinical outcome by down regulation of lymph dissemination factor VEGF-C expression in vivo: oral and IV modalities.
Abbasi MM; Monfaredan A; Hamishehkar H; Seidi K; Jahanban- Esfahlan R
Asian Pac J Cancer Prev; 2014; 15(15):6227-32. PubMed ID: 25124602
[TBL] [Abstract][Full Text] [Related]
3. DOX-MTX-NPs augment p53 mRNA expression in OSCC model in rat: effects of IV and oral routes.
Abbasi MM; Khiavi MM; Monfaredan A; Hamishehkar H; Seidi K; Jahanban-Esfahlan R
Asian Pac J Cancer Prev; 2014; 15(19):8377-82. PubMed ID: 25339032
[TBL] [Abstract][Full Text] [Related]
4. Oral and IV dosages of doxorubicin-methotrexate loaded- nanoparticles inhibit progression of oral cancer by down- regulation of matrix Methaloproteinase 2 expression in vivo.
Abbasi MM; Jahanban-Esfahlan R; Monfaredan A; Seidi K; Hamishehkar H; Khiavi MM
Asian Pac J Cancer Prev; 2014; 15(24):10705-11. PubMed ID: 25605162
[TBL] [Abstract][Full Text] [Related]
5. Comparison of injectable doxorubicin & its nanodrug complex chemotherapy for the treatment of 4-nitroquinoline-1-oxide induced oral squamous cell carcinoma in rats.
Khiavi MM; Abdal K; Abbasi MM; Hamishehkar H; Aghbali AA; Salehi R; Sina M; Abdollahi B; Fotohi S
Indian J Med Res; 2017 Jan; 145(1):112-117. PubMed ID: 28574023
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the Blood Parameters, Cardiac and Liver Enzymes in Oral Squamous Cell Carcinoma Following Treated with Injectable Doxorubicin-Loaded Nano-Particles.
Moradzadeh Khiavi M; Anvari E; Hamishehkar H; Abdal K
Asian Pac J Cancer Prev; 2019 Jul; 20(7):1973-1977. PubMed ID: 31350953
[TBL] [Abstract][Full Text] [Related]
7. Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatment.
Wang D; Xu X; Zhang K; Sun B; Wang L; Meng L; Liu Q; Zheng C; Yang B; Sun H
Int J Nanomedicine; 2018; 13():187-198. PubMed ID: 29343957
[TBL] [Abstract][Full Text] [Related]
8. Hesa-A Down-Regulates erb/b2 Oncogene Expression and Improves Outcome of Oral Carcinoma in a Rat Model.
Abbasi MM; Mehdipour M; Monfaredan A; Jahanban-Esfahlan R
Asian Pac J Cancer Prev; 2015; 16(16):6947-51. PubMed ID: 26514473
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
10. Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery.
Lee JY; Termsarasab U; Lee MY; Kim DH; Lee SY; Kim JS; Cho HJ; Kim DD
Acta Biomater; 2017 Jul; 57():262-273. PubMed ID: 28483700
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
12. The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate.
Ray L; Kumar P; Gupta KC
Biomaterials; 2013 Apr; 34(12):3064-76. PubMed ID: 23357370
[TBL] [Abstract][Full Text] [Related]
13. Comparison of methotrexate and sequential methotrexate-5-fluorouracil for patients with recurrent squamous cell carcinoma of the oral cavity.
Airoldi M; Pedani F; Brando V; Gabriele P; Orecchia R
Chemioterapia; 1987 Dec; 6(6):390-2. PubMed ID: 3435920
[TBL] [Abstract][Full Text] [Related]
14. [Polyelectrolyte layer-by-layer assembled lipid nanoparticles for improving oral absorption of doxorubicin].
Shen AJ; Xia DN; Gan Y; Li J
Yao Xue Xue Bao; 2016 Jul; 51(7):1136-43. PubMed ID: 29897223
[TBL] [Abstract][Full Text] [Related]
15. ERBB2 gene amplification in oral squamous cell malignancies: a correlation with tumor progression and gene expression.
Chu F; Feng Q; Qian Y; Zhang C; Fang Z; Shen G
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jul; 112(1):90-5. PubMed ID: 21531597
[TBL] [Abstract][Full Text] [Related]
16. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
Park JW; Hong K; Kirpotin DB; Colbern G; Shalaby R; Baselga J; Shao Y; Nielsen UB; Marks JD; Moore D; Papahadjopoulos D; Benz CC
Clin Cancer Res; 2002 Apr; 8(4):1172-81. PubMed ID: 11948130
[TBL] [Abstract][Full Text] [Related]
17. Anti-invasion and anti-tumor growth effect of doxycycline treatment for human oral squamous-cell carcinoma--in vitro and in vivo studies.
Shen LC; Chen YK; Lin LM; Shaw SY
Oral Oncol; 2010 Mar; 46(3):178-84. PubMed ID: 20036604
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance.
Zhang D; Kong YY; Sun JH; Huo SJ; Zhou M; Gui YL; Mu X; Chen H; Yu SQ; Xu Q
Int J Nanomedicine; 2017; 12():2081-2108. PubMed ID: 28356731
[TBL] [Abstract][Full Text] [Related]
19. Enhanced chemotherapeutic efficacy of the low-dose doxorubicin in breast cancer via nanoparticle delivery system crosslinked hyaluronic acid.
Wang Q; Zhong Y; Liu W; Wang Z; Gu L; Li X; Zheng J; Du H; Zhong Z; Xie F
Drug Deliv; 2019 Dec; 26(1):12-22. PubMed ID: 30691317
[TBL] [Abstract][Full Text] [Related]
20. Redox and pH-responsive gold nanoparticles as a new platform for simultaneous triple anti-cancer drugs targeting.
Ghorbani M; Hamishehkar H
Int J Pharm; 2017 Mar; 520(1-2):126-138. PubMed ID: 28167261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]